- About Us
- Patient & Family Care
- Education & Events
- Research & Clinical Trials
- For Medical Professionals
- Support Our Mission
- News & Media For Media Professionals Press Releases Video Channel
Press Releases: News at Banner Alzheimer’s
The following press releases highlight recent developments in key programs, events and research activities at Banner Alzheimer’s Institute. If you are a member of the media and would like more information for a story, use the following contacts:
- To reach a member of our media team weekdays from 8 a.m.-5 p.m., email firstname.lastname@example.org
- After hours, call our on-call media line (after 5 p.m., weekends, holidays): (602) 492-4770
2017 press releases and news
$5M Grant Awarded to Arizona-Based Alzheimer’s Research Collaboration
Funds will establish an unprecedented resource to clarify Alzheimer’s disease mechanisms and discover new treatments
Phoenix (September 13, 2017) – The Banner Alzheimer’s Foundation has been awarded a $5 million grant on behalf of several Arizona-based research institutions to develop an unprecedented public resource of molecular data to help advance the scientific understanding, treatment and prevention of Alzheimer’s disease.
Clinical Trial Of a New Investigational Drug, SUVN502, For People with Alzheimer’s
Phoenix (September 13, 2017) – An investigational drug for people living with Alzheimer’s disease, is being tested in clinical trials at Banner Alzheimer’s Institute (BAI), under the direction of principal investigators, Dr. William Burke (in Phoenix) and Dr. Edward Zamrini (in Sun City).
Banner Alzheimer’s Institute Receives Added NIH Support
Five-year funding expected to total $14.8 million to support groundbreaking Alzheimer’s Prevention Initiative
Phoenix (May 23, 2017) – The National Institute on Aging (NIA), part of the National Institutes of Health, has provided additional funding for the Banner Alzheimer’s Institute (BAI) to complete a pioneering Alzheimer’s prevention trial in Medellin, Colombia. New funding continues crucial support to evaluate an investigational medicine in members of the world’s largest extended family who carry a rare genetic mutation making them virtually certain to develop Alzheimer’s symptoms by the average age of 44.
Eric M. Reiman, MD, and Pierre N. Tariot, MD, were featured on the January 23, 2017 episode of Arizona Horizon on Arizona PBS. The Banner Alzheimer's Institute leaders discussed the latest advances in Alzheimer’s disease research with host Ted Simons.
2016 press releases and news
- Banner Alzheimer's Institute Featured on CBS 60 Minutes
Phoenix (November 27, 2016) – Banner Alzheimer’s Institute (BAI) was featured on CBS 60 Minutes in November 2016, highlighting the Institute’s groundbreaking efforts to advance a new era of Alzheimer’s prevention. The two-part story focused on the trial of an experimental anti-amyloid treatment aimed at preventing Alzheimer’s in members of the world’s largest autosomal dominant Alzheimer’s kindred in Colombia, South America. The kindred includes more than 5,000 living family members with more than one thousand of them carrying a rare genetic mutation that typically triggers Alzheimer’s symptoms around age 45.
- Pioneering Alzheimer’s Prevention Study Starts Enrolling High-Risk Older Adults
Phoenix (August 23, 2016) – Researchers from the Banner Alzheimer’s Institute (BAI) today announced they have begun enrolling the first participants in a multi-site study to determine whether two investigational anti-amyloid compounds—an active immunotherapy and an oral medication—can prevent or delay the emergence of symptoms of Alzheimer’s in people identified by genetic markers as being at particularly high risk for developing the disease at older ages.
- Banner Alzheimer’s Foundation reaches $40 million fundraising goal
Phoenix (April 20, 2016) – Banner Alzheimer’s Institute has solidified its position as the place “where hope begins and Alzheimer’s ends,” thanks to the generosity of nearly 3,000 individuals, corporations and foundations who contributed to the BAI Breakthrough Campaign.
2015 press releases and news
- Banner Alzheimer’s Institute and Mayo Clinic Arizona to Participate in Multi-Center Study of Chronic Traumatic Encephalopathy in Former Football Players
Phoenix (December 22, 2015) – Researchers from Phoenix-based Banner Alzheimer’s Institute (BAI) and Mayo Clinic Arizona will participate in a new $16 million federally funded study of former professional and college football players, attempting to create methods to detect and diagnose a serious brain disease known as chronic traumatic encephalopathy (CTE) before death.
- Alzheimer’s Prevention Registry Reaches Significant Milestone of 200,000 Enrollees
Phoenix (December 16, 2015) – The Alzheimer’s Prevention Registry (APR) enrolled its 200,000th volunteer interested in participating in studies aimed at preventing the disease, a significant milestone in the fight against Alzheimer’s.
New Program Launched to Advance Alzheimer’s Prevention Research
GeneMatch to connect volunteers to research studies aimed at late-onset Alzheimer’s
Phoenix (December 8, 2015) – Banner Alzheimer’s Institute (BAI) announced the launch of GeneMatch, a first-of-its-kind program designed to identify a large group of people interested in volunteering for Alzheimer’s research studies based in part on their APOE genetic information.
- Cooperation Advances Alzheimer’s Disease Prevention Research
Chicago and Phoenix (September 29, 2015) – The future success of Alzheimer’s prevention research could depend on the ability of researchers from different clinical trials to build collaborative relationships that facilitate the sharing of information, resources and expertise that may speed the discovery of new preventive treatments, according to leading Alzheimer's researchers who published a Perspectives article, "CAP-advancing the evaluation of preclinical Alzheimer disease treatments," online today in Nature Reviews Neurology.
- $10,000 donation supports Alzheimer’s prevention research at Banner Alzheimer’s Institute
Phoenix (June 12, 2015) – Banner Alzheimer’s Foundation is the recipient of a $10,000 donation from Visiting Angels Scottsdale, following a yearlong fundraising initiative by the organization. Contributions from the senior home care service will support Banner Alzheimer’s Institute (BAI) in its prevention research working to end the devastating disease without losing another generation.
- Arizona State University and Banner Health launch major effort to fight neurodegenerative diseases
Tempe, Arizona (June 10, 2015) – Arizona State University and Banner Health today announced a new research alliance to advance the scientific study, treatment and prevention of Alzheimer's, Parkinson's and other neurodegenerative diseases. The partnership between Arizona State University (ASU), one of the nation's largest public research universities, and Phoenix-based Banner Health, one of the nation's largest nonprofit health systems, includes the launch of a new Arizona State University-Banner Neurodegenerative Disease Research Center on ASU's Tempe campus.
Banner Alzheimer’s Institute Receives $10 Million in New Funding for Alzheimer’s Prevention Trial
BAI moves the dial in ending devastating disease
Phoenix (June 8, 2015) – Phoenix-based Banner Alzheimer’s Institute (BAI), an internationally-known Alzheimer’s care and research center, has taken another momentous leap forward toward reaching a fundraising campaign goal of $40 million, with the help of $10 million in new research funding.
- Banner Alzheimer's Institute Receives $10 Million in New Research Funding for Alzheimer's Prevention Trial
Phoenix (May 29, 2015) – Phoenix-based Banner Alzheimer's Institute (BAI), an internationally-known Alzheimer's care and research center, has taken another momentous leap forward toward reaching a fundraising campaign goal of $40 million, with the help of $10 million in new research funding. The Alzheimer’s Association, GHR Foundation and Fidelity Biosciences Research Initiative, collectively announced new research funding to support a groundbreaking Alzheimer's disease prevention trial that will commence later this year.
- Banner Alzheimer's Institute welcomes new physician and researcher
Phoenix (April 15, 2015) – Garrett Riggs, PhD, MD, an experienced behavioral neurologist with more than 15 years of practice and research experience, is the newest provider in the Stead Family Memory Center at Phoenix-based Banner Alzheimer’s Institute, an internationally-known Alzheimer’s care and research center.
- New PET image analysis technique tracks amyloid changes and evaluates potential Alzheimer's treatments with greater power
Phoenix (March 19, 2015) – Researchers from Banner Alzheimer's Institute (BAI) have developed a new brain image analysis method to better track the progression of beta-amyloid plaque deposition, a characteristic brain abnormality in Alzheimer's disease, according to a study published in the March issue of the Journal of Nuclear Medicine. Investigators also believe this new approach may make it easier to evaluate investigational anti-amyloid treatments in clinical trials.
- Alzheimer's Prevention Registry Reaches Significant Milestone of 100,000 Enrollees
Online community helping to accelerate critical Alzheimer’s research
Phoenix (Feb. 3, 2015) – The Alzheimer’s Prevention Registry today enrolled its 100,000th volunteer interested in participating in studies aimed at preventing the disease, a significant milestone in the fight against Alzheimer's. Championed by Banner Alzheimer's Institute (BAI), in collaboration with partner organizations and leading scientists, the Registry (www.endALZnow.org) aims to accelerate prevention research by establishing an online community of healthy individuals who are committed to fighting the disease, informing them about the latest developments in Alzheimer's prevention research, and connecting those who may be interested with scientists carrying out the studies.
- Banner Alzheimer's Institute offers free memory screenings on Jan. 30
Phoenix (Jan. 15, 2015) – Banner Alzheimer’s Institute is conducting free memory screenings in collaboration with the Via Linda Senior Center and the ASU College of Nursing & Healthcare Innovation from 9 a.m. to 1 p.m. on Friday, Jan. 30 at Via Linda Senior Center, 10440 N. Via Linda in Scottsdale.
- Banner Alzheimer's Foundation hosting 'A Night to Remember' with private documentary screening
Phoenix (Jan. 13, 2015) – Banner Alzheimer’s Foundation and Women Inspiring Scientific Progress (WISP) are proud to invite community members to "A Night to Remember" from 5:30 to 8 p.m. on Monday, Jan. 26 at the Musical Instrument Museum, 4725 E. Mayo Blvd. in Phoenix.
- Banner Alzheimer's Institute to offer monthly webinars featuring dementia education
Phoenix (Jan. 9, 2015) – Banner Alzheimer’s Institute has announced a new, free webinar series entitled "Dementia Dialogues," to provide caregivers with helpful information and tools to better understand and care for loved ones living with dementia.
2014 press releases and news
Alzheimer’s Prevention Registry Reaches Recruitment Milestone of 40,000 Individuals
Online community helping to accelerate critical Alzheimer’s research
Phoenix (August 25, 2014) – The Alzheimer’s Prevention Registry today reached a significant milestone in the fight against Alzheimer’s by enrolling the 40,000th volunteer interested in participating in major studies of the disease.
NIH Renews Funding of Banner Alzheimer’s Institute and Mayo Clinic Decades-Long Longitudinal Study of Earliest Alzheimer’s Disease Changes
Phoenix (August 6, 2014) – The National Institutes of Health (NIH) renewed funding for the Banner Alzheimer’s Institute (BAI) and Mayo Clinic, Phoenix, longitudinal study of the earliest changes associated with the risk of developing Alzheimer’s disease at older ages.
Banner Alzheimer’s Institute Announces Partnership with Novartis in New Study of Alzheimer’s Prevention Treatments
Two drugs to be studied in North America and Europe in volunteers at high risk for disease
Copenhagen, Denmark (July 15, 2014) – Researchers from the Banner Alzheimer’s Institute (BAI) today announced a partnership with Novartis in a pioneering medical trial to determine whether two investigational anti-amyloid drugs—an active immunotherapy and an oral medication—can prevent or delay the emergence of symptoms of Alzheimer’s in people at particularly high risk for developing the disease at older ages.